Kanagawa, Japan

Yoshio Furutani

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent. Top assignees: Agency of Industrial Science and Technology, Ministry of International Trade & Industry, Mitsui Toatsu Chemicals, Incorporated. Active years: 1986-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshio Furutani. Retrieved from https://idiyas.com/inventor/yoshio-furutani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Chiba, JP (1986)
  • Yokohama, JP (1988)
  • Miura, JP (1988 - 1992)
  • Kanagawa, JP (1991 - 1992)
  • Miuragun, JP (1989 - 1997)

Company Filing History:


Years Active: 1986-1997

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Yoshio Furutani: Pioneer of Recombinant DNA Technologies**

Introduction

Yoshio Furutani, based in Kanagawa, Japan, is a prominent inventor known for his significant contributions to the field of biotechnology. With a portfolio of 8 patents, he has made substantial advancements in recombinant DNA technologies, focusing on the production of proteins using host bacteria.

Latest Patents

Furutani's latest patents showcase his innovative approaches to genetic engineering. One notable patent involves a DNA base sequence that comprises regions essential for the production of proteins, specifically detailing a neutral protease gene from Bacillus amyloliquefaciens. This gene includes critical components such as the promoter region, ribosome binding region, secretion region, structural gene, and terminator region. These segments are crucial for constructing recombinant DNA that facilitates the extracellular production of proteins, enhancing yield during culturing processes.

Another significant patent details the modification of HV1-type hirudin, wherein valine at the N-terminal end and aspartic acid at the 5th residue are replaced by alanine and glutamic acid, respectively. By integrating a DNA sequence coding for a precursor with a secretion signal into bacterial strains of the genus Bacillus, Furutani enables the efficient secretion of the modified HV1-type hirudin while preserving its thrombin inhibiting activity.

Career Highlights

Furutani has held pivotal roles in esteemed organizations, including the Agency of Industrial Science and Technology and Mitsui Toatsu Chemicals, Incorporated. His work in these institutions has facilitated his focus on innovative biotechnological research, leading to several important patents that have significantly impacted the industry.

Collaborations

Throughout his career, Furutani has collaborated with esteemed colleagues, including Masaru Honjo and Hiroaki Shimada. These partnerships have enriched his research endeavors and expanded the scope of his innovative projects, reflecting a commitment to collaboration in advancing scientific research.

Conclusion

Yoshio Furutani's contributions to the field of biotechnology exemplify the impact of innovative thinking and collaboration. With his extensive patent portfolio and a dedication to advancing recombinant DNA technologies, he remains a notable figure in the scientific community, inspiring future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…